R H Herzig

ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR CHRONIC MYELOGENOUS LEUKAEMIA

B Speck, M. M. Bortin, Richard Champlin et al. · The Lancet · 1984 · 266 citations

Medicine, Hematology, Immunology +8

High-dose cytosine arabinoside therapy with and without anthracycline antibiotics for remission reinduction of acute nonlymphoblastic leukemia.

R H Herzig, Hillard M. Lazarus, Steven N. Wolff et al. · Journal of Clinical Oncology · 1985 · 182 citations

Medicine, Oncology, Pharmacotherapy +17

Intensive chemotherapy with cyclophosphamide, carmustine, and etoposide followed by autologous bone marrow transplantation for relapsed Hodgkin's disease.

Donna Reece, Michael J. Barnett, J M Connors et al. · Journal of Clinical Oncology · 1991 · 176 citations

Medicine, Oncology, Pharmacology +16

Cerebellar toxicity with high-dose cytosine arabinoside.

R H Herzig, John Hines, Geoffrey P. Herzig et al. · Journal of Clinical Oncology · 1987 · 164 citations

Pharmacy, Oncology, Pharmacology +16

Intensive melphalan chemotherapy and cryopreserved autologous bone marrow transplantation for the treatment of refractory cancer.

Hillard M. Lazarus, R H Herzig, John Graham‐Pole et al. · Journal of Clinical Oncology · 1983 · 150 citations

Medicine, Pharmacology, Hematologic Oncology +15